ESC 365 - Early initiation of disease-modifying therapy in patients with suspected heart failure

ESC2025 Premium Access

Early initiation of disease-modifying therapy in patients with suspected heart failure

Session: Late Breaking Clinical Science: global insights and outcomes in heart failure

Topic: Treatment

Speaker: Doctor K. Docherty (Glasgow, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Kieran Docherty

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

12 presentations

4 followers

3 more presentations in this session

ESC HF III Registry - primary analysis: outcomes

Speaker: Professor L. Lund (Stockholm, SE)

Temporal Trends in HF Outcomes

Speaker: Professor J. Youn (Seoul, KR)

THESUS HF II Acute Heart Failure in Africa

Speaker: Professor K. Sliwa (Cape Town, ZA)

Access the full session

Late Breaking Clinical Science: global insights and outcomes in heart failure

Speakers: Doctor K. Docherty, Professor L. Lund, Professor J. Youn, Professor K. Sliwa

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources